Redefining chimeric antigen receptor T-cell (CAR-T) regulation: China’s responses to address secondary cancer risks of CAR-T therapy
Crossref DOI link: https://doi.org/10.1186/s13045-024-01602-0
Published Online: 2024-10-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tan, Ruirong
Li, Rui
Dai, Meng-Yuan
Liu, Miao
Zhao, Junning
Text and Data Mining valid from 2024-10-08
Version of Record valid from 2024-10-08
Article History
Received: 19 July 2024
Accepted: 23 August 2024
First Online: 8 October 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.